| A renaissance for SRC TJ Yeatman Nature Reviews Cancer 4 (6), 470-480, 2004 | 1418 | 2004 |
| Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Nature medicine 14 (8), 822-827, 2008 | 1122 | 2008 |
| Role of Src expression and activation in human cancer RB Irby, TJ Yeatman Oncogene 19 (49), 5636-5642, 2000 | 1088 | 2000 |
| Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA MC Liu, GR Oxnard, EA Klein, C Swanton, MV Seiden, MC Liu, ... Annals of Oncology 31 (6), 745-759, 2020 | 1018 | 2020 |
| Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer CE Cox, S Pendas, JM Cox, E Joseph, AR Shons, T Yeatman, NN Ku, ... Annals of surgery 227 (5), 645-653, 1998 | 840 | 1998 |
| Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer JJ Smith, NG Deane, F Wu, NB Merchant, B Zhang, A Jiang, P Lu, ... Gastroenterology 138 (3), 958-968, 2010 | 695 | 2010 |
| Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis T Bowman, MA Broome, D Sinibaldi, W Wharton, WJ Pledger, JM Sedivy, ... Proceedings of the National Academy of Sciences 98 (13), 7319-7324, 2001 | 648 | 2001 |
| Activating SRC mutation in a subset of advanced human colon cancers RB Irby, W Mao, D Coppola, J Kang, JM Loubeau, W Trudeau, R Karl, ... Nature genetics 21 (2), 187-190, 1999 | 621 | 1999 |
| Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies D Coppola, M Szabo, D Boulware, P Muraca, M Alsarraj, AF Chambers, ... Clinical cancer research 10 (1), 184-190, 2004 | 602 | 2004 |
| Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests RFA Logan, J Patnick, C Nickerson, L Coleman, MD Rutter, ... Gut 61 (10), 1439-1446, 2012 | 600 | 2012 |
| Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling D Agrawal, T Chen, R Irby, J Quackenbush, AF Chambers, M Szabo, ... Journal of the National Cancer Institute 94 (7), 513-521, 2002 | 528 | 2002 |
| Within the fold: assessing differential expression measures and reproducibility in microarray assays IV Yang, E Chen, JP Hasseman, W Liang, BC Frank, S Wang, V Sharov, ... Genome biology 3, 1-13, 2002 | 501 | 2002 |
| Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer RN Jorissen, P Gibbs, M Christie, S Prakash, L Lipton, J Desai, D Kerr, ... Clinical Cancer Research 15 (24), 7642-7651, 2009 | 477 | 2009 |
| Molecular staging for survival prediction of colorectal cancer patients S Eschrich, I Yang, G Bloom, KY Kwong, D Boulware, A Cantor, ... Journal of Clinical Oncology 23 (15), 3526-3535, 2005 | 457 | 2005 |
| lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling Y Lu, X Zhao, Q Liu, C Li, R Graves-Deal, Z Cao, B Singh, JL Franklin, ... Nature medicine 23 (11), 1331-1341, 2017 | 365 | 2017 |
| Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer S Kaiser, YK Park, JL Franklin, RB Halberg, M Yu, WJ Jessen, ... Genome biology 8, 1-26, 2007 | 359 | 2007 |
| A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation SA Eschrich, J Pramana, H Zhang, H Zhao, D Boulware, JH Lee, G Bloom, ... International Journal of Radiation Oncology* Biology* Physics 75 (2), 489-496, 2009 | 351 | 2009 |
| Local excision of T2 and T3 rectal cancers after downstaging chemoradiation CJ Kim, TJ Yeatman, D Coppola, A Trotti, B Williams, JS Barthel, ... Annals of surgery 234 (3), 352-359, 2001 | 342 | 2001 |
| Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling D Coppola, M Nebozhyn, F Khalil, H Dai, T Yeatman, A Loboda, JJ Mulé The American journal of pathology 179 (1), 37-45, 2011 | 332 | 2011 |
| EMT is the dominant program in human colon cancer A Loboda, MV Nebozhyn, JW Watters, CA Buser, PM Shaw, PS Huang, ... BMC medical genomics 4, 1-10, 2011 | 327 | 2011 |
